TABLE 2.
Primer no. | type | Primer sequencesa |
---|---|---|
802 | Forward | 5′CTCGAGCCCTAACCCTAACCCCCCAAATTTTCACC3′ |
729 | Reverse | 5′AAGCTTGCCTTCCACCCGCCACGTGTG3′ |
M165 | Forward | 5′CTCGAGCAAGAGATCGGCGTTGCTTTC3′ |
M166 | Reverse | 5′AAGCTTGCCTTCCACCCGCCACGCGTG3′ |
782 | Forward | 5′CTCGAGTCCCCGCCGCCAATAGCTAC3′ |
730 | Reverse | 5′AAGCTTGCCTTCCACCCGCTTTTTTTGCCGGGGGAACCCCGCGTGGGGCTCTTG3′ |
718 | Reverse | 5′GGGGAACCCCGCGTGGGGCTCTTGTAGCTTTTTTCGCCTACGCCCACCGCGC3′ |
719 | Reverse | 5′AAGCTTGCCTTCCACCCGCCACGTGTGCCGGGGGAACCCCGCGTGGGGCTCTTGTA3′ |
700 | Reverse | 5′GAACCCCGCGTGGGGCTTTTTTTGCTTCCTCCGCCTAC3′ |
701 | Reverse | 5′AAGCTTGCCTTCCACCCGCCACGTGTGCCGGGGGAACCCCGCGTGGGGC3′ |
M270 | Forward | 5′CTCGAGTCTTTTTTGCCAATAGCTACGCGGCAGC3′ |
M271 | Reverse | 5′CCCCGCGTGGGGCTCTTGTAGCTTCCTCTTTTTTTTTTCACCGCGCGCCTATTG3′ |
M171 | Reverse | 5′GAACCCCGCGTGGGGCTTTTTTTGCCTCCTCCGCCTAC3′ |
M178 | Reverse | 5′AAGCTTGCCTTCCACCCGCCACGCGTGCCGGGGGAACCCCGCGTGGGGC3′ |
713 | Forward | 5′AAACTTGGATTATGCAAGTG3′ |
712 | Reverse | 5′CACTTGCATAATCCAAGTTTTTTTTACATCACAGGTGGTATGTG3′ |
715 | Forward | 5′GTACACCTGCCTGCACTACT3′ |
714 | Reverse | 5′AGTAGTGCAGGCAGGTGTACTTTTTCCTGTCGGCCGCGAGAGG3′ |
717 | Forward | 5′GCATGGGGCGTGGCGGGAGA3′ |
716 | Reverse | 5′TCTCCCGCCACGCCCCATGCTTTTTCCCCGCCCCTTCCTGTGG3′ |
703 | Forward | 5′AGCTACGCGGCAGCGTACAGCCCGG3′ |
702 | Reverse | 5′ACGCTGCCGCGTAGCTTTTTTCGGCGGGGAGGAGAGCG3′ |
705 | Forward | 5′AGGCGCGCGGTGGGCGTAGG3′ |
704 | Reverse | 5′TACGCCCACCGCGCGCCTTTTTTCCGGGCTGTACGCTGCC3′ |
M168 | Forward | 5′AGCGGGGCGGCAGCGTGCAGCCCGG3′ |
M167 | Reverse | 5′ACGCTGCCGCCCCGCTTTTTTCCGCGGGGAGGAGAGCGGG3′ |
M170 | Forward | 5′GGGCGCCCGGTGGGCGTAGG3′ |
M169 | Reverse | 5′TACGCCCACCGGGCGCCCTTTTTCCGGGCTGCACGCTGCC3′ |
804 | Forward | 5′TGGCGGGAGATGAATGACCG3′ |
M180 | Forward | 5′GCATCGGACCCCGCGGGCCCACAGGAAGGGG3′ |
Point mutations with respect to the wild-type sequences of the vTR and chTR promoters are in bold and restriction sites are underlined.